Erik Lefkofsky on the Forefront of Effective Cancer Treatment

The fight to cure cancer has been an ongoing battle in our society for decades. In 2014, The National Cancer Institute estimates that 14.5 million US citizens were fighting the disease, a number that is predicted to reach 19 million by 2024. Though, thanks to inviduals like Erik Lefkofsky and companies like Tempus, those battling cancer do not have to do it alone and can count on these individuals and companies who are continually trying to improve their care.

Erik Lefkofsky co-founded Tempus with the objective to transform they way individuals faced with cancer receive treatment. Everyday advances are being made in how cancer is both diagnosed and treated. Tempus has been leading the way in precision medicine, pioneering the way that patient information is taken and analyzed. By creating models that incorporates some of the most important data in a patients care, physician notes, this model comes equipped with natural language processing and character recognition making it so that all data collected on a patient is specific to their individual cases, significantly improving the effectiveness of finding the right treatment course.

Erik Lefkofsky, an entrepreneur and philanthropist, has had an intimate relationship with cancer when him and his wife first founded Tempus as his wife’s sister passed away from it, and it was only later that his wife as well was diagnosed with breast cancer. The effort in revolutionizing the way those battling cancer receive their care is an objective that has had personal meaning to Lefkofsky.

Lefkofsky has found himself successful in many of his endeavors and investments in technological advances that have potential to improve the future for all, but it is in his feats of aiding those who are caring for a loved with cancer or who are fighting the disease themselves, that demonstrates the mark that Lefkofsky is trying to make, a stronger tomorrow.

Jeremy Goldstein: Law for one, law for all!

In a recent article for Law Blog for the Average Joe, Jeremy Goldstein outlined the pros and cons of no longer offering stock options to employees as an employment benefit or perk. Jeremy goes on to warn that this is not the best of options as it is something that could due to an uncertain economic market, be rendered as worthless to the employees. He does suggest that knockout options could be beneficial in allowing the shareholders and employees a better chance to see a value in the stock options. Goldstein ends the article by asking businesses to consider six month waiting periods for stock options in order to protect the integrity of the value of the company’s stock.

 

Jeremy Goldstein has been practicing law for over 15 years and is an expert at offering business advice. Jeremy graduated from the New York Law School in 1999 after which he went on to work for Shearman & Sterling LLP and Wachtell, Lipton, Rosen & Katz until starting his own practice 2014. Goldstein’s academic achievements include a bachelor of the arts from Cornell University and a masters degree in the arts from the University of Chicago. In addition to running a busy practice, Jeremy concentrates on philanthropic efforts support such charities as Fountain House, the world’s leading model for mental health treatment for people living with serious mental illness. He also represents those who are in need a legal help that is not within the normal scope of his usual corporate advisory, including those most vulnerable who are assisted by Fountain House.

 

Anyone, from any walk of life who is in need of legal advice, should contact Mr. Goldstein at 917.596.2955 or jeremy.goldstein@jlgassociates.com

Learn more: https://www.americanconference.com/executive-compensation-836l17-nyc/speakers/jeremy-goldstein/